Globus Medical

Company Profile

Globus Medical had its IPO on 2012-08-03 under the ticker symbol GMED.

The company operates in the Healthcare sector and Medical Devices industry. Globus Medical has a staff strength of 2,600 employees.

Stock update

Shares of Globus Medical opened at $50.87 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $49.93 - $50.97, and closed at $50.04.

This is a -1.98% slip from the previous day's closing price.

A total volume of 1,090,400 shares were traded at the close of the day’s session.

In the last one week, shares of Globus Medical have slipped by -7.73%.

Globus Medical's Key Ratios

Globus Medical has a market cap of $7.14 billion, indicating a price to book ratio of 4.2108 and a price to sales ratio of 7.2354.

In the last 12-months Globus Medical’s revenue was $1.10 billion with a gross profit of $759.12 million and an EBITDA of $318.48 million. The EBITDA ratio measures Globus Medical's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Globus Medical’s operating margin was 22.59% while its return on assets stood at 7.51% with a return of equity of 11.09%.

In Q2, Globus Medical’s quarterly earnings growth was a positive 7.5% while revenue growth was a positive 10.6%.

Globus Medical’s PE and PEG Ratio

Forward PE

32.2581

Trailing PE

27.0106

PEG

2.928

Its diluted EPS in the last 12-months stands at $1.89 per share while it has a forward price to earnings multiple of 32.2581 and a PEG multiple of 2.928. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Globus Medical’s profitability.

Globus Medical stock is trading at a EV to sales ratio of 7.0345 and a EV to EBITDA ratio of 26.1379. Its price to sales ratio in the trailing 12-months stood at 7.2354.

Globus Medical stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$2.21 billion

Total Liabilities

$155.22 million

Operating Cash Flow

$52.22 million

Capital Expenditure

$17.87 million

Dividend Payout Ratio

0%

Globus Medical ended 2024 with $2.21 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $2.21 billion while shareholder equity stood at $1.99 billion.

Globus Medical ended 2024 with $5.30 million in deferred long-term liabilities, $155.22 million in other current liabilities, 100000.00 in common stock, $1.35 billion in retained earnings and $198.93 million in goodwill. Its cash balance stood at $306.45 million and cash and short-term investments were $612.83 million. The company’s total short-term debt was $1,758,000 while long-term debt stood at $0.

Globus Medical’s total current assets stands at $1.21 billion while long-term investments were $391.52 million and short-term investments were $306.38 million. Its net receivables were $241.94 million compared to accounts payable of $33.81 million and inventory worth $335.56 million.

In 2024, Globus Medical's operating cash flow was $52.22 million while its capital expenditure stood at $17.87 million.

Comparatively, Globus Medical paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$50.04

52-Week High

$80.04

52-Week Low

$49.93

Analyst Target Price

$67.18

Globus Medical stock is currently trading at $50.04 per share. It touched a 52-week high of $80.04 and a 52-week low of $80.04. Analysts tracking the stock have a 12-month average target price of $67.18.

Its 50-day moving average was $57.3 and 200-day moving average was $61.33 The short ratio stood at 10.03 indicating a short percent outstanding of 0%.

Around 108.3% of the company’s stock are held by insiders while 9884.4% are held by institutions.